Department of Otolaryngology, Head and Neck Surgery, University Hospital Giessen and Marburg, Marburg, Germany.
Head Neck. 2014 Feb;36(2):231-4. doi: 10.1002/hed.23289. Epub 2013 Jun 14.
Carcinomas of the oropharyngeal and hypopharynx are difficult to treat because of their aggressive tendency to metastasize and their high recurrence rate.
A retrospective review of 79 patients with recurrences of oropharyngeal or hypopharyngeal carcinomas was performed. The courses of disease from recurrence diagnosis to the valuation date or death were analyzed.
The median survival for patients classified as incurable at recurrence diagnosis amounted to 8 months (95% confidence interval [CI], 5-10 months), patients initially classified as curable at the time of recurrence diagnosis survived an estimated 12 months (95% CI, 8-22 months). No significant differences regarding the survival after diagnosed recurrence could be observed depending on the tumor location or tumor stage.
The knowledge about the courses of disease and especially the remaining lifetime after diagnosed incurability could facilitate the planning of the remaining lifetime in order to achieve the best possible quality of life.
口咽和下咽癌由于其转移的侵袭性倾向和高复发率,治疗难度较大。
对 79 例口咽或下咽癌复发患者进行回顾性分析。分析从复发诊断到评估日期或死亡的疾病过程。
复发诊断时被归类为无法治愈的患者的中位生存期为 8 个月(95%置信区间[CI],5-10 个月),最初在复发诊断时被归类为可治愈的患者估计可存活 12 个月(95%CI,8-22 个月)。肿瘤位置或肿瘤分期与复发后生存时间之间无显著差异。
了解疾病过程,特别是在诊断为不可治愈后剩余的寿命,可以帮助规划剩余的寿命,以实现尽可能好的生活质量。